medigraphic.com
Colegio de Medicos y Cirujanos República de Costa Rica

2013, Number 608

<< Back Next >>

Rev Med Cos Cen 2013; 70 (608)

Hipotiroidismo subclínico

Callaú BA

Language: Spanish
References: 23
Page: 615-620
PDF size: 170.93 Kb.


ABSTRACT

Currently, the screening for subclinical hypothyroidism is highly debated, the benefits of its treatment are more appealing today, but there’s still not enough definitive scientific evidence to approve a therapeutic protocol, excepting obstetric patients whose treatment is a priority. Studying patients with subclinical hypothyroidism involves a comprehensive and individualized approach, assessing risk factors and estimating benefits.


REFERENCES

  1. Baloch, Z., Carayon, P., Conte- Devolx, B., Demers, L., Feldt- Rasmussen, U., Henry, J., et Al (2003) Laboratory medicine practice guidelines. EL4 Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3–126.

  2. Boucai, L., Hollowell, J. & Surks, M. (2011) An approach for development of age-, gender-, and ethnicityspecific thyrotropin reference limits. Thyroid 21: 5–11.

  3. Caraccio N, Ferrannini E & Monzani F. (2002) Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebocontrolled study. J Clin Endocrinol Metab 87: 1533–1538.

  4. Dardano A, Caraccio N & Monzani F. (2006) Evaluation of endothelial function in subclinical thyroid dysfunction. Thyroid 16:200–201.

  5. Dessein P, Joffe B & Stanwix A. (2004) Subclinical hypothyroidism is associated with insulin resistance in rheumatoid arthritis. Thyroid 14:443–446.

  6. Garber J, Cobin R, Gharib H, Hennessey J, Klein I, Mechanick J et Al.(2012). Clinical Practice Guidelines for Hypothyroidism in Adults. Thyroid Volume 22, Number 12, 1200-1235.

  7. Gardner, D & Shoback, D. (2012) Glándula Tiroides. En D. Cooper, Endocrinología Básica y Clínica de Greenspan (9° Ed pp 163-226). Mexico DF.

  8. Gencer B, Collet TH, Virgini V, Bauer D, Gussekloo J, Cappola AR, et Al (2012) Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from six prospective cohorts. Circulation 126:1040–1049.

  9. Hollowell J, Staehling N, Flanders W, Gunter E, Spencer C & Braverman L. (2002) Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 87:489–499

  10. Huber G, Staub J, Meier C, Mitrache C, Guglielmetti M, Huber P, et Al (2002) Prospective study of the spontaneous course of subclinical hypothyroidism: prognostic value of thyrotropin, thyroid reserve, and thyroid antibodies. J Clin Endocrinol Metab 87:3221–3226.

  11. Iqbal A, Jorde R & Figenschau Y. (2006) Serum lipid levels in relation to serum thyroid-stimulating hormone and the effect of thyroxine treatment on serum lipid levels in subjects with subclinical hypothyroidism: the Tromso Study. J Intern Med 260:53–61.

  12. Kubota S, Fujiwara M, Hagiwara H, Tsujimoto N, Takata K, Kudo, T, et Al (2010) Multiple thyroid cysts may be a cause of hypothyroidism in patients with relatively high iodine intake. Thyroid 20:205–208.

  13. Melmed S, Polonsky K, Larsen P. & Kronenberg H. (2011). Hypothyroidism and Thyroiditis. En G. Brent & T. Davies, Williams Textbook of Endocrinology (12° Ed pp 406-439) Philadelphia.

  14. Miller MJ, Pan C & Barzel U. (1990) The prevalence of subclinical hypothyroidism in adults with lownormal blood thyroxine levels. NY State J Med 90:541–544.

  15. Negro R, Schwartz A, Gismondi R, Tinelli A, Mangieri T & Stagnaro A. ( 2011) Thyroid antibody positivity in the first trimester of pregnancy is associated with negative pregnancy outcomes. J Clin Endocrinol Metab 96:E920–924.

  16. Rodondi N, den Elzen W, Bauer D, Cappola A, Razvi S, Walsh JP,et Al (2010) Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304:1365– 1374

  17. Serter R, Demirbas B, Korukluoglu B, Culha C, Cakal E & Aral Y. (2004) The effect of L-thyroxine replacement therapy on lipid based cardiovascular risk in subclinical hypothyroidism. J Endocrinol Invest 27:897–903.

  18. Stagnaro A, Roman S, Cobin R, Harazy E, Alvarez M & Davies T. (1990) Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 264:1422–1425.

  19. Surks M & Hollowell J. (2007) Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab 92:4575–4582

  20. Taddei S, Caraccio N, Virdis A, Dardano A, Versari D, Ghiadoni L, et Al. (2003) Impaired endotheliumdependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88:3731–3737.

  21. Teixeira P, Reuters V, Ferreira M, Almeida C, Reis F, Melo B, et Al (2008) Treatment of subclinical hypothyroidism reduces atherogenic lipid levels in a placebo-controlled double-blind clinical trial. Horm Metab Res 40: 50–55

  22. Vanderpump M, Tunbridge W, French J, Appleton D, Bates D, Clark F, Grimley J, et Al (1995) The incidence of thyroid disorders in the community: a twenty-year followup of the Whickham Survey. Clin Endocrinol (Oxf ) 43:55–68.

  23. Wartofsky l & Dickey R (2005). Controversy in endocrinology: The Evidence for a Narrower Thyrotropin Reference Range Is Compelling. The Journal of Clinical Endocrinology & Metabolism 90(9):5483–5488.




2020     |     www.medigraphic.com